Favorites Sign in
  1. Home
  2. Companies
  3. Eli Lilly and Company
  4. Financial Ratios
  5. P/S Ratio
Eli Lilly and Company logo
Eli Lilly and Company LLY
$ 1 277.31 -0.56%
report update icon

Quarterly report 2026-Q2
added 08-05-2026

Eli Lilly and Company P/S Ratio | LLY

Annual P/S Ratio Eli Lilly and Company

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
14.4 17.3 19.5 10.4 7.97 7.43 6.12 4.89 3.96 3.87 4.38 4.08 2.57 2.75 1.8 1.56 1.74 2.56 - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
19.5 1.56 6.52

P/S Ratio of other stocks in the Biotechnology industry

Issuer P/S Ratio Price % 24h Market Cap Country
Infinity Pharmaceuticals Infinity Pharmaceuticals
INFI
 		6.54 - -46.98 % $ 3.57 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		11.2 - - $ 7.46 M israelIsrael
BioDelivery Sciences International BioDelivery Sciences International
BDSI
 		1.85 - -4.8 % $ 255 M usaUSA
Morphic Holding Morphic Holding
MORF
 		2.91 K - - $ 2.42 B usaUSA
Novan Novan
NOVN
 		1.11 - -24.84 % $ 2.64 M usaUSA
Genocea Biosciences Genocea Biosciences
GNCA
 		44.3 - -15.0 % $ 3.04 M usaUSA
Equillium Equillium
EQ
 		1.77 $ 1.23 -0.41 % $ 70.5 M usaUSA
Eiger BioPharmaceuticals Eiger BioPharmaceuticals
EIGR
 		0.197 - -9.21 % $ 2.55 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		13.5 - -0.23 % $ 916 M usaUSA
BELLUS Health BELLUS Health
BLU
 		106 K - - $ 2.47 B canadaCanada
bluebird bio bluebird bio
BLUE
 		0.114 - - $ 546 M usaUSA
Intra-Cellular Therapies Intra-Cellular Therapies
ITCI
 		66.5 - - $ 13.6 B usaUSA
Marinus Pharmaceuticals Marinus Pharmaceuticals
MRNS
 		16 - - $ 29.6 M usaUSA
Merrimack Pharmaceuticals Merrimack Pharmaceuticals
MACK
 		0.804 - - $ 216 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
 		3.79 - - $ 35.4 M usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
 		3.08 - - $ 728 M usaUSA
Aptinyx Aptinyx
APTX
 		204 - -39.0 % $ 4.57 M usaUSA
TRACON Pharmaceuticals TRACON Pharmaceuticals
TCON
 		0.489 - -1.38 % $ 46.8 M usaUSA
Edesa Biotech Edesa Biotech
EDSA
 		158 $ 2.56 -7.58 % $ 14.5 M usaUSA
Mirati Therapeutics Mirati Therapeutics
MRTX
 		206 - - $ 3.3 B usaUSA
Revance Therapeutics Revance Therapeutics
RVNC
 		2.05 - - $ 309 M usaUSA
Epizyme Epizyme
EPZM
 		3.37 - - $ 249 M usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
 		5.55 - -9.72 % $ 5.89 M usaUSA
Forward Pharma A/S Forward Pharma A/S
FWP
 		7.83 - -0.75 % $ 18.7 M danmarkDanmark
Orchard Therapeutics plc Orchard Therapeutics plc
ORTX
 		29.7 - 1.02 % $ 90.8 M britainBritain
La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company
LJPC
 		1.68 - - $ 154 M usaUSA
Oyster Point Pharma Oyster Point Pharma
OYST
 		12.7 - - $ 300 M usaUSA
Nabriva Therapeutics plc Nabriva Therapeutics plc
NBRV
 		0.111 - - $ 4.55 M irlandaIrlanda
Intercept Pharmaceuticals Intercept Pharmaceuticals
ICPT
 		9.15 - - $ 643 M usaUSA
NGM Biopharmaceuticals NGM Biopharmaceuticals
NGM
 		28.8 - - $ 127 M usaUSA
Regulus Therapeutics Regulus Therapeutics
RGLS
 		4.86 - - $ 155 M usaUSA
9 Meters Biopharma 9 Meters Biopharma
NMTR
 		38.5 - -42.97 % $ 1.05 M usaUSA
Chinook Therapeutics Chinook Therapeutics
KDNY
 		227 - - $ 2.6 B usaUSA
Lumos Pharma Lumos Pharma
LUMO
 		12 - - $ 35.3 M usaUSA
Syros Pharmaceuticals Syros Pharmaceuticals
SYRS
 		16.6 - -8.44 % $ 3.4 M usaUSA
Citius Pharmaceuticals Citius Pharmaceuticals
CTXR
 		1.82 K $ 0.45 13.31 % $ 4.98 M usaUSA
Aravive Aravive
ARAV
 		6.61 - -13.39 % $ 1.45 M usaUSA
Novo Nordisk A/S Novo Nordisk A/S
NVO
 		0.708 $ 39.12 0.17 % $ 174 B danmarkDanmark
Abeona Therapeutics Abeona Therapeutics
ABEO
 		43.3 $ 4.33 -1.7 % $ 229 M usaUSA
AIM ImmunoTech AIM ImmunoTech
AIM
 		12.9 $ 0.16 3.97 % $ 259 K usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
 		1.42 $ 0.63 11.85 % $ 162 M usaUSA